DOCSLIB.ORG

2018 PTOS Manual

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2018 PTOS Manual 2018 PENNSYLVANIA TRAUMA SYSTEMS FOUNDATION OPERATIONAL MANUAL FOR THE DATA BASE COLLECTION SYSTEM 1 TABLE OF CONTENTS TOPIC PAGE NUMBER PREFACE .................................................................................................................................................. 10 GENERAL INSTRUCTIONS ........................................................................................................................ 12 PTOS PATIENT INCLUSION CRITERIA ....................................................................................................... 14 SECTION I: DEMOGRAPHIC DATA .......................................................................................................... 18 INSTITUTION NUMBER .............................................................................................................. 19 ZIP CODE OF RESIDENCE ........................................................................................................... 19 RACE .......................................................................................................................................... 19 ETHNICITY ................................................................................................................................. 20 SEX ............................................................................................................................................. 20 DATE OF BIRTH .......................................................................................................................... 20 AGE ............................................................................................................................................ 20 PRIMARY ICD-10 MECHANISM (EXTERNAL CAUSE OF MORBIDITY (ICD-10-CM))/ PRIMARY CAUSE OF INJURY E-CODE (ICD-9) ............................................................................................ 21 PRIMARY CAUSE OF INJURY- External Cause of Morbidity (ICD-10-CM) SPECIFY/(E-CODE SPECIFY (ICD-9)) ........................................................................................................................ 21 SECONDARY ICD-10 MECHANISM - External Cause of Morbidity (ICD-10-CM)/(E-CODE (ICD-9)) ................................................................................................................................................... 22 HEIGHT OF FALL ........................................................................................................................ 22 PLACE OF INJURY OF THE EXTERNAL CAUSE (Y92)(ICD-10)/( PLACE OF INJURY E-CODE (E849.X)(ICD-9) .......................................................................................................................... 23 PLACE OF INJURY EXTERNAL CAUSE CODE- ICD-10-CM/ E-CODE (ICD-9) SPECIFY ................... 23 ACTIVITY E-CODE (OPTIONAL ELEMENT FOR ALL TRAUMA CENTERS) ..................................... 24 INJURY DATE ............................................................................................................................. 24 INJURY TIME .............................................................................................................................. 24 COUNTY OF INJURY (STATE IF NOT PA) .................................................................................... 24 COUNTY OF INJURY (STATE IF NOT PA) IF OTHER..................................................................... 24 PROTECTIVE DEVICES ................................................................................................................ 25 PRIMARY - TYPE OF INJURY ....................................................................................................... 25 SECONDARY -TYPE OF INJURY ................................................................................................... 26 TYPE OF BURN INJURY .............................................................................................................. 26 PRE-EXISTING CONDITIONS ...................................................................................................... 26 SECTION II: PREHOSPITAL DATA ............................................................................................................ 27 SECTION II: PREHOSPITAL DATA ............................................................................................... 28 WAS PATIENT EXTRICATED? ..................................................................................................... 28 WERE SCENE PROVIDER AND TRANSPORT PROVIDER THE SAME? .......................................... 28 ARE ANY SCENE PROVIDER DATA AVAILABLE? ......................................................................... 28 PROVIDER – SCENE AND/OR TRANSPORT ................................................................................ 30 DATES AND TIMES – SCENE AND/OR TRANSPORT ................................................................... 30 AMBULANCE SCENE TIME (auto calculation) ........................................................................... 31 AMBULANCE CODE – SCENE AND/OR TRANSPORT .................................................................. 31 2 January 2018 Grey Highlighted area = addition or revision AMBULANCE UNIT NUMBER – SCENE AND/OR TRANSPORT ................................................... 31 WAS PATIENT CARE RECORD (PCR) AVAILABLE? – SCENE AND/OR TRANSPORT (FLTR 2) ....... 31 PATIENT CARE RECORD NUMBER – SCENE AND/OR TRANSPORT ............................................ 32 LIFE SUPPORT – HIGHEST LEVEL OF PROVIDER (SCENE AND/OR TRANSPORT) ...................... 32 LIFE SUPPORT – HIGHEST LEVEL OF CARE (SCENE AND/OR TRANSPORT)............................... 32 WAS A COMPLETE SET OF VITAL SIGNS (INCLUDING GCS) TAKEN PRIOR TO THE PATIENT LEAVING THE SCENE OF INJURY? .............................................................................................. 33 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT (PULSE RATE/MINUTE) ................ 33 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT (UNASSISTED RESPIRATORY RATE/MINUTE) .......................................................................................................................... 34 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT (SYSTOLIC BLOOD PRESSURE) ...... 34 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT (GCS-EYE OPENING) ..................... 35 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT (GCS-VERBAL RESPONSE) ............ 35 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT (GCS-MOTOR RESPONSE) ............ 36 PREHOSPITAL VITAL SIGNS - GCS QUALIFIERS – Matches NTDB Initial ED/Hospital GCS Assessment Qualifiers ............................................................................................................... 37 PREHOSPITAL VITAL SIGNS – GCS QUALIFIERS – PARALYZING DRUGS SPECIFY ....................... 38 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT (INTUBATED W/ ARTIFICIAL AIRWAY) .................................................................................................................................... 38 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT - IS PATIENT’S RESPIRATORY RATE CONTROLLED? (BAGGING OR VENTILATOR) ............................................................................ 39 PREHOSPITAL VITAL SIGNS – SCENE AND/OR TRANSPORT-CONTROLLED RESPIRATORY RATE ................................................................................................................................................... 39 REFERRING FACILITY - IS THIS A TRANSFER PATIENT? .............................................................. 39 REFERRING FACILITY – IS THERE DATA/INFORMATION AVAILABLE FROM OUTSIDE FACILITY? ................................................................................................................................................... 40 REFERRING FACILITY - DATE AND TIME OF ADMISSION AT REFERRING FACILITY .................... 40 REFERRING FACILITY - DATE AND TIME OF DISCHARGE FROM REFERRING FACILITY .............. 40 REFERRING FACILITY LENGTH OF STAY (Auto Calculation) ....................................................... 40 REFERRING FACILITY - DIAGNOSTIC INTERVENTIONS AT REFERRING FACILITY ....................... 41 REFERRING FACILITY - THERAPEUTIC INTERVENTIONS AT REFERRING FACILITY ..................... 43 REFERRING FACILITY - REFERRAL FROM FACILITY NUMBER..................................................... 44 REFERRING FACILITY – UNRESOLVED OCCURRENCES .............................................................. 44 REFERRING FACILITY - IS REFERRAL FACILITY CLINICAL DATA AVAILABLE? .............................. 44 REFERRING FACILITY (PULSE RATE/MINUTE) ........................................................................... 44 REFERRING FACILITY (UNASSISTED RESPIRATORY RATE/MINUTE) .......................................... 45 REFERRING FACILITY (SYSTOLIC BLOOD PRESSURE) ................................................................. 45 REFERRING FACILITY (GCS-EYE OPENING) ................................................................................ 45 REFERRAL FACILITY (GCS-VERBAL RESPONSE) .......................................................................... 46 REFERRING FACILITY (GCS-MOTOR RESPONSE)........................................................................ 47 REFERRING FACILITY - GCS QUALIFIERS - Matches NTDB Initial ED/Hospital GCS ................... 47 Assessment Qualifiers ............................................................................................................... 47 REFERRING
Load more

Recommended publications
  • Bone Development P1 Abstract Withdrawn P2 Treatment Of
    Bone development P1 Abstract withdrawn P2 Treatment of partial growth arrest using cylindrical costal osteochondral graft Ryo Orito (Osaka, Japan) P3 Abstract withdrawn P4 Applicability of the Tanner-Whitehouse 3 method to United Kingdom children born in the 21st century Khalaf Alshamrani (Sheffield, United Kingdom) P5 Response of bone to mechanical stimulation in the offspring of MAVIDOS study mothers in a single centre; the effect of antenatal vitamin D supplementation. Sujatha Gopal (Sheffield, United Kingdom) P6 Pseudohypoparathyroidism type Ib initially masquerading as epileptic seizures due to Fahr´s disease Stepan Kutilek (Pardubice, Czech Republic) P7 Bone morphology patterns in children with osteogenesis imperfecta Cathleen Raggio (New York, United States) P8 Polyhydramnios: sole risk factor for non-traumatic fractures in two infants Geneviève Nadeau (Montreal, Canada) P9 Do lifestyle factors play a role on bone health in boys diagnosed with Autism Spectrum Disorder? Preliminary data from the Promoting bone and gut health in our children (PROUD) study Rachel L Duckham (Geelong, Australia) P10 Radiographic evidence of zoledronic acid given during pregnancy – a case report Amanda Peacock (Sheffield, United Kingdom) P11 Reference values of cortical thickness, bone width, and Bone Health Index in metacarpals of children from age 0 y, as determined with an extension of the fully automated BoneXpert bone age method Peter Thrane (Hørsholm, Denmark) P12 Abstract withdrawn P13 Clinical implications of modeling the maturational spurt Melanie
    [Show full text]
  • Subspecialty Rotation: Radiology Primary Goals for This Rotation 6.72 GOAL: Normal Vs
    Subspecialty Rotation: Radiology Primary Goals for this Rotation 6.72 GOAL: Normal vs. Abnormal (Radiology). Differentiate normal from abnormal features on radiographs. 6.72.1 : Examine radiographs in a systematic manner. 6.72.2 : Interpret radiographs accurately, recognizing the characteristic patterns by which physiologic and morphologic alterations are demonstrated. 6.72.3 : Differentiate common normal variants and developmental features from pathologic conditions on plain radiographs. 6.73 GOAL: Interpreting Common Radiographs (Radiology). Order and interpret radiographic studies in common and emergency conditions. 6.73.1 : Request the radiographic study needed to clarify a clinical problem. 6.73.2 : Communicate key patient information related to the radiographic study to the radiologist. 6.73.3 : Manage patients effectively using radiographic information. 6.73.4 : Interpret common findings on radiographs accurately. For example, identify the following features on commonly obtained radiographs: 1. Abdominal radiographs: abdominal masses, fecaliths, free intraperitoneal air, ileus, congenital and acquired intestinal obstruction, pneumatosis intestinalis, intraperitoneal and retroperitoneal calcifications 2. Chest radiographs: atelectasis, airspace and interstitial pulmonary disease, cardiomegaly, foreign bodies, abnormalities of lung volume pneumothorax, pleural fluid, tumors, abnormal pulmonary vascularity, vascular anomalies 3. Extremity radiographs: benign and malignant bone tumors, cysts, bone destruction, common fractures [Salter-Harris
    [Show full text]
  • Diagnostic Imaging Data in Manitoba: Assessment and Applications
    Diagnostic Imaging Data in Manitoba: Assessment and Applications June 2004 Manitoba Centre for Health Policy Department of Community Health Sciences Faculty of Medicine, University of Manitoba Gregory Finlayson, BA, CAE with: William Leslie, MD, FRCPC, MSc Sandor Demeter, MD, FRCPC Leonard MacWilliam, MSc, MNRM Lisa Lix, PhD Roger Philipp, MD, FRCPC Martin Reed, MD, FRCPC ISBN 1-896489-17-6 Ordering Information If you would like to receive a copy of this or any other of our reports, contact us at: Manitoba Centre for Health Policy University of Manitoba 4th Floor, Room 408 727 McDermot Avenue Winnipeg, Manitoba, Canada R3E 3P5 Order line: 204-789-3805 Fax: 204-789-3910 Or you can visit our WWW site at: http://www.umanitoba.ca/centres/mchp/reports.htm © Manitoba Health For reprint permission contact the Manitoba Centre for Health Policy THE MANITOBA CENTRE FOR HEALTH POLICY The Manitoba Centre for Health Policy (MCHP) is located within the Department of Community Health Sciences, Faculty of Medicine, University of Manitoba. The mission of MCHP is to provide accurate and timely information to health care decision-makers, analysts and providers, so they can offer services which are effective and efficient in maintaining and improving the health of Manitobans. Our researchers rely upon the unique Population Health Research Data Repository to describe and explain pat- terns of care and profiles of illness, and to explore other factors that influ- ence health, including income, education, employment and social status. This Repository is unique in terms of its comprehensiveness, degree of inte- gration, and orientation around an anonymized population registry.
    [Show full text]
  • Neuroradiology Back to the Future: Brain Imaging
    Published December 8, 2011 as 10.3174/ajnr.A2936 50TH ANNIVERSARY PERSPECTIVES Neuroradiology Back to the Future: Brain Imaging E.G. Hoeffner SUMMARY: The beginning of neuroradiology can be traced to the early 1900s with the use of skull S.K. Mukherji radiographs. Ventriculography and pneumoencephalography were introduced in 1918 and 1919, re- spectively, and carotid angiography, in 1927. Technical advances were made in these procedures A. Srinivasan during the next 40 years that lead to improved diagnosis of intracranial pathology. Yet, they remained D.J. Quint invasive procedures that were often uncomfortable and associated with significant morbidity. The introduction of CT in 1971 revolutionized neuroradiology. Ventriculography and pneumoencephalogra- phy were rendered obsolete. The imaging revolution continued with the advent of MR imaging in the early 1980s. Noninvasive angiographic techniques have curtailed the use of conventional angiography, and physiologic imaging gives us a window into the function of the brain. In this historical review, we will trace the origin and evolution of the advances that have led to the quicker, less invasive diagnosis and resulted in more rapid therapy and improved outcomes. ABBREVIATIONS: CPA ϭ cerebellopontine angle; EDH ϭ epidural hematoma; LP ϭ lumbar punc- ture; NMR ϭ nuclear magnetic resonance; SDH ϭ subdural hematoma fforts to image the CNS began with skull radiographs duced by trauma, surgery, or infection.3 Skull radiographs Eshortly after Roentgen’s discovery of x-rays.1-3 In the early were also used to diagnose fractures and foreign bodies.9 20th century, contrast studies of the brain, by using air for Obtaining a single skull radiograph took minutes, with the contrast, were developed with the introduction of ventriculog- radiograph being produced on a glass plate with a slowly re- raphy and pneumoencephalography.4,5 Shortly thereafter, ce- sponding photographic emulsion.
    [Show full text]
  • Clinical Utility of Arterial Spin-Labeling As a Confirmatory
    CLINICAL REPORT BRAIN Clinical Utility of Arterial Spin-Labeling as a Confirmatory Test for Suspected Brain Death K.M. Kang, T.J. Yun, B.-W. Yoon, B.S. Jeon, S.H. Choi, J.-h. Kim, J.E. Kim, C.-H. Sohn, and M.H. Han ABSTRACT SUMMARY: Diagnosis of brain death is made on the basis of 3 essential findings: coma, absence of brain stem reflexes, and apnea. Although confirmatory tests are not mandatory in most situations, additional testing may be necessary to declare brain death in patients in whom results of specific components of clinical testing cannot be reliably evaluated. Recently, arterial spin-labeling has been incorpo- rated as part of MR imaging to evaluate cerebral perfusion. Advantages of arterial spin-labeling include being completely noninvasive and providing information about absolute CBF. We retrospectively reviewed arterial spin-labeling findings according to the following modified criteria based on previously established confirmatory tests to determine brain death: 1) extremely decreased perfusion in the whole brain, 2) bright vessel signal intensity around the entry of the carotid artery to the skull, 3) patent external carotid circulation, and 4) “hollow skull sign” in a series of 5 patients. Arterial spin-labeling findings satisfied the criteria for brain death in all patients. Arterial spin-labeling imaging has the potential to be a completely noninvasive confirmatory test to provide additional information to assist in the diagnosis of brain death. ABBREVIATION: ASL ϭ arterial spin-labeling rain death is defined as irreversible loss of brain and brain bioelectrical activity, electroencephalography is used in many Bstem function.
    [Show full text]
  • Whole‑Body Low‑Dose Computed Tomography in Multiple Myeloma
    2490 ONCOLOGY LETTERS 13: 2490-2494, 2017 Whole‑body low‑dose computed tomography in multiple myeloma staging: Superior diagnostic performance in the detection of bone lesions, vertebral compression fractures, rib fractures and extraskeletal findings compared to radiography with similar radiation exposure LUKAS LAMBERT1, PETR OUREDNICEK2, ZUZANA MECKOVA3, GIAMPAOLO GAVELLI4, JAN STRAUB5 and IVAN SPICKA5 1Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague; 2Department of Imaging Methods, St. Anne's University Hospital in Brno, 656 91 Brno; 3Institute of Nuclear Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic; 4Radiology Unit, IRCCS‑Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), I‑47014 Meldola, Italy; 5Department of Hematology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic Received July 14, 2016; Accepted November 17, 2016 DOI: 10.3892/ol.2017.5723 Abstract. The primary objective of the present prospec- detected more rib fractures compared with CR (188 vs. 47; tive study was to compare the diagnostic performance of P<0.0001), vertebral compressions (93 vs. 67; P=0.010) and conventional radiography (CR) and whole-body low-dose extraskeletal findings (194 vs. 52; P<0.0001). There was no computed tomography (WBLDCT) with a comparable radia- correlation observed between lesion size (≥5 mm) and its tion dose reconstructed using hybrid iterative reconstruction attenuation (r=‑0.006; P=0.93). The inter‑observer agree- technique, in terms of the detection of bone lesions, skeletal ment for the presence of osteolytic lesions was κ=0.76 for fractures, vertebral compressions and extraskeletal findings.
    [Show full text]
  • Correlation of Bone Histology with Parathyroid Hormone, Vitamin D3, and Radiology in End-Stage Renal Disease
    Kidney International, Vol. 44 (1993), PP. 1071—1077 Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease ALASTAIR J. HUTCHISON, RIcK W. WHITEHOUSE, HELEN F. BOULTON, JUDY E. ADAMS, E. BARBARA MAWER, TONY J. FREEMONT, and RAM GOKAL Renal Dialysis Unit, Manchester Royal Infirmary, Departments of Diagnostic Radiology, Medicine, and Osteoarticular Pathology, University of Manchester, Oxford Road, Manchester, England, United Kingdom Correlation of bone histology with parathyroid hormone, vitamin D3, times in conjuction with a desfemoxamine mesylate infusion and radiology in end-stage renal disease. We analyzed transiliac bone test), and plain skeletal X-rays (the so-called "skeletal sur- biopsy specimens from 30 end-stage renal failure patients, taken at the time of admission for CAPD training. Results were compared withvey"). However, as pointed out by Malluche and Faugere, values of iPTH, bone alkaline phosphatase, I ,25-dihydroxyvitamin D3, serum biochemical parameters are relatively poor predictors of skeletal survey, quantitative computed tomography (QCT) and singlethe type and severity of bone disease, while information ob- photon absorptiometry (SPA) bone density measurements. Osteitistained from skeletal X-rays is limited and often misleading. In fibrosa was the most common histological diagnosis, present in 15 of the addition most radiologic signs considered to be pathognomonic 30 patients (50%), with eight classified as "severe" and seven as "mild." Eight patients (27%) had adynamic bone lesion, four mixed of severe osteitis fibrosa can be found in any of the three renal osteodystrophy (13%), and two (7%) osteomalacia. The mean age histological types of renal osteodystrophy [1]. of the adynamic group was higher than the osteitis fibrosa group (41 In recent years, other techniques have been developed for 12.1vs.
    [Show full text]
  • Early-Infantile Galactosialidosis: Clinical and Radiological Findings
    Open Access Case Report J Clin Med Case Reports November 2015 Volume 2, Issue 2 © All rights are reserved by Escobar et al. Journal of Early-Infantile Galactosialidosis: Clinical & Medical Clinical and Radiological Findings Case Reports Callyn B. Riggs1, Luis F. Escobar2*, and Megan E. 2 Keywords: Galactosialidosis; Non-immune hydrops; Dysostosis; Tucker Neonatal ascites 1Department of Pediatrics, Peyton Manning Children’s Hospital, Indianapolis, IN 46260, USA Abstract 2Medical Genetics & Neurodevelopmental Center, Peyton Manning Galactosialidosis is a rare lysosomal storage disorder. Very few Children’s Hospital, Indianapolis, IN 46260, USA reports of the early-infantile (EIGS) form can be found in the literature. *Address for Correspondence: This form typically presents with prenatal non-immune fetal hydrops Luis F. Escobar, MD, Medical Genetics & Neurodevelopmental associated with various complex postnatal clinical findings. We discuss Center, Peyton Manning Children’s Hospital, 8402 Harcourt Rd, here a case of EIGS seen in our center due to prenatal diagnosis of #300, Indianapolis, IN 46260, USA, Tel: 317-338-5288; Fax: 317- non-immune hydrops with significant abdominal ascites. Postnatally, 338-7154; E-mail: [email protected] the patient was found to have persistent ascites, multiple congenital Submission: 19 August 2015 anomalies, cholestasis, and thrombocytopenia. Radiologic findings Accepted: 29 October 2015 suggested osteochondrodysplasia, which in association with the other Published: 03 November 2015 clinical findings indicated the possibility of a lysosomal storage disorder, Copyright: © 2015 Riggs CB, et al. This is an open access article such as early-infantile galactosialidosis. We review and discuss here the distributed under the Creative Commons Attribution License, which clinical and radiographic findings in EIGS as described in the literature permits unrestricted use, distribution, and reproduction in any medium, and compare them to our case study.
    [Show full text]
  • Radiology Order Sheet
    Imaging Subspecialists of North Jersey, LLC Bhanu Aluri, MD Edward Millman, MD Romulo H. Balthazar Prashant Parashurama, MD Patrick J. Conte, MD Orestes Sanchez, MD Madelyn Dano, MD Robin Frank-Gerzberg, MD Frank R. Yuppa, MD Steven Kwon, MD OneOne Bay Ba Avenuey Avenue • Montclair • Mon NtclairJ, 07042 NJ, 07042 Chairman of Radiology Waren Frietag Central Scheduling: 973-873-7787 or 877-523-7787; Fax 973-680-7946 Medical Director Kalavathy Balakumar (973) 429-6106 - MRI (973) 429-6110 - Nuclear/PET (973) 429-6111 Marianne Centann Radiology Today’s Date: Patient Name: Clinical Signs/Symptoms: ICD9 Code: AAuthorization/uthorized/PreP-rcee-rCertt Number Number ( * R(ifE Qavailable)UIRED P:rior__________________________________________________________________________________ to Appointment): _______________ Referring Physician Name: Phone: Referring Physician Signature: Fax: Wet Reading Patient to Return with Images LAB - BUN Creatinine (For IV contrast if no recent labs) MRI GENERAL RADIOGRAPHY * CT (DUAL SOURCE MULTI-SLICE) Head/Brain Chest Esophagram IVP Head/Brain Chest IAC’s Abdomen UGI Series KUB Sinuses Abdomen Nasopharynx Pelvis Small Bowel Series Obstructive Series Facial Pelvis Orbits Brachial Plexus Upper GI with small bowel Neck (Soft Tissue) Orbits Cervical Spine Pituitary Neck (Soft Tissue) Barium Enema Chest Mandible Thoracic Spine Perfusion Cervical Spine VCUG Skeletal Survey Neck (Soft Tissue) Lumbar Spine TMJ Thoracic Spine Skull Series Cervical Spine NON CONTRAST CONTRAST MRI Spectroscopy Lumbar Spine Nasal Bones Thoracic
    [Show full text]
  • Neurosonology: Transcranial Doppler
    1 Neurosonology: Transcranial Doppler Mark N. Rubin, M.D. Vascular & Hospital Neurology, Neurosonology Assistant Professor of Neurology Email: [email protected] Google Scholar _______________________________ Northwest Neurology https://www.northwestneuro.com/ 2 Contents Transcranial Doppler (TCD) Services and Indications ........................................................................ 3 What is TCD? ............................................................................................................................... 3 What can be accomplished with TCD? .......................................................................................... 3 When is TCD useful? .................................................................................................................... 3 Overview of TCD Ultrasonography ................................................................................................... 4 General Principles of TCD ............................................................................................................. 4 TCD Technique ............................................................................................................................. 7 Patient Safety .............................................................................................................................. 7 Evidence Compendium by Indication ............................................................................................... 8 Cerebrovascular Disease .............................................................................................................
    [Show full text]
  • Cerebral Angiography
    Cerebral Angiography Cerebral angiography uses a catheter, x-ray imaging guidance and an injection of contrast material to examine blood vessels in the brain for abnormalities such as aneurysms and disease such as atherosclerosis (plaque). The use of a catheter makes it possible to combine diagnosis and treatment in a single procedure. Cerebral angiography produces very detailed, clear and accurate pictures of blood vessels in the brain and may eliminate the need for surgery. Your doctor will instruct you on how to prepare, including any changes to your medication schedule. Tell your doctor if there's a possibility you are pregnant and discuss any recent illnesses, medical conditions, medications you're taking, and allergies, especially to iodinated contrast materials. If you're breastfeeding, ask your doctor how to proceed. If you are to be sedated, you may be told not to eat or drink anything for four to eight hours before your procedure. Also, you should plan to have someone drive you home. Leave jewelry at home and wear loose, comfortable clothing. You will be asked to wear a gown. What is Cerebral Angiography Angiography is a minimally invasive medical test that uses x-rays and an iodine-containing contrast material to produce pictures of blood vessels in the brain. In cerebral angiography, a thin plastic tube called a catheter is inserted into an artery in the leg or arm through a small incision in the skin. Using x-ray guidance, the catheter is navigated to the area being examined. Once there, contrast material is injected through the tube and images are captured using ionizing radiation (x-rays).
    [Show full text]
  • ASPNR INTERESTING CASE SESSION ASNR 54Th Annual Meeting May 24,23, 2016
    ASPNR INTERESTING CASE SESSION ASNR 54th Annual Meeting May 24,23, 2016 Erin Simon Schwartz, MD, President Susan Palasis, MD, Vice-President Ashok Panigrahy, MD, Secretary Arastoo Vossough, MD, PhD, Treasurer and Laurence Eckel, MD, Treasurer IN WHAT YEAR WAS THE ASPNR FOUNDED? A.1992 B. 1993 C.1994 D.1995 E. 1996 IN WHAT YEAR WAS THE ASPNR FOUNDED? A.1992 B. 1993 C.1994 D.1995 E. 1996 ESS CASE 1 11 year old girl “progressively obtunded and vomiting” WHAT IS THE DIAGNOSIS? A. Subdural hygromas B. Subarachnoid hemorrhage C. Anemia D. Iatrogenic effect WHAT IS THE DIAGNOSIS? A. Subdural hygromas B. Subarachnoid hemorrhage C. Anemia D. Iatrogenic effect Additional history we found in the medical record: Patient with seizures and rapidly declining mental status after local anesthetic (mepivicaine) injected for dental procedure INTRAVASCULAR LIPID ADMINISTRATION • Lipid infusions increasingly being used to treat local anesthetic systemic toxicity (LAST) • Possible antidotal effect of intravenous lipid emulsion on action of lipophilic drugs, including local anesthetics, first discovered in 1962 • First case reports of success in human in 2006 • Controversial, however, as efficacy and safety not clearly proven Lipid Rescue - Efficacy and Safety Still Unproven. Höjer J, Jacobsen D, Neuvonen PJ, Rosenberg PH. Basic Clin Pharmacol Toxicol. 2016 May 2. doi: 10.1111/bcpt.12607. [Epub] PMID: 27136445 SP CASE 1 • 7 month old previously healthy full term male • Found unresponsive in daycare • Caregiver stated that the baby choked while taking the bottle Non C+ CT + Retinal hemorrhages Negative skeletal survey 3D Volume rendering T2 FSE T2 FSE FS TOF MRA TOF MRV WHAT IS THE DIAGNOSIS? A.
    [Show full text]